As of 2024-12-12, the EV/EBITDA ratio of Genomic Vision SA (GV.PA) is -0.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GV.PA's latest enterprise value is 1.66 mil EUR. GV.PA's TTM EBITDA according to its financial statements is -7.39 mil EUR. Dividing these 2 quantities gives us the above GV.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
Range | Selected | |
Trailing P/E multiples | 6.5x - 8.8x | 7.1x |
Forward P/E multiples | 6.9x - 8.8x | 7.1x |
Fair Price | (0.13) - (0.17) | (0.14) |
Upside | -7597.7% - -9639.3% | -7789.1% |
Date | EV/EBITDA |